Amgen AMGN
NASDAQ AMGN
$407.27 -14.24 (-3.38%)
At close: Oct 1, 2026 · 4:00 PM EDT

Amgen (AMGN) Finished Goods (2013 - 2017)

Updated

Amgen's Finished Goods was $1.11 billion in Q2 2017, down 4.6% from the prior quarter.

Analysis

Amgen (AMGN) Finished Goods (2013 - 2017) Analysis & Trends

At the end of FY2016, Finished Goods at Amgen came in at $912 million, up 29.4% from FY2015.

  • Finished Goods shows a three-year compound annual growth rate of 7.3% (FY2013 to FY2016).
  • In earlier years, Finished Goods was $705 million in FY2015 (-21.5%), $898 million in FY2014 (+21.7%) and $738 million in FY2013.
  • Quarterly Finished Goods has moved between $705 million (Q4 2015) and $1.16 billion (Q1 2017) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 1.11 Bn
Mar 31, 2017 1.16 Bn
Dec 31, 2016 912.00 Mn
Mar 31, 2016 783.00 Mn
Dec 31, 2015 705.00 Mn
Sep 30, 2015 962.00 Mn
Jun 30, 2015 1.03 Bn
Dec 31, 2014 898.00 Mn
Jun 30, 2014 916.00 Mn
Dec 31, 2013 738.00 Mn
API Access

Amgen Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=AMGN&period=max&api_key=YOUR_API_KEY